ロード中...
Combination treatment in HBeAg-negative chronic hepatitis B
Chronic hepatitis B (CHB) represents an important public health problem. HBeAg-negative CHB is frequently associated with advanced liver disease and its prevalence is increasing. Monotherapy with either interferon (conventional or pegylated) or nucleoside/nucleotide analogues has its limitations. It...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Co., Limited
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2999254/ https://ncbi.nlm.nih.gov/pubmed/21160964 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v1.i1.43 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|